Kansas City Royals

Ask VT AI
View News Summary
  • Chime Financial, a fintech company focused on no-fee banking, made a strong Nasdaq debut, raising $864 million and highlighting its growing traction among underserved consumers.
  • BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
  • Supreme Court revives lawsuit against FBI over mistaken home raid, setting precedent for law enforcement accountability.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News
Ask VT AI
View News Summary
  • Chime Financial, a fintech company focused on no-fee banking, made a strong Nasdaq debut, raising $864 million and highlighting its growing traction among underserved consumers.
  • BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
  • Supreme Court revives lawsuit against FBI over mistaken home raid, setting precedent for law enforcement accountability.
20 hours
USA flag

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Kansas City Royals